Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Obstet Gynaecol Res. 2012 May 21;38(12):1343–1351. doi: 10.1111/j.1447-0756.2012.01880.x

Table 1.

Baseline hemodynamics

Control Caffeine A1 antagonist
(CPT)
A2A antagonist
(MSX-3)
p-value
Mother HR (/min) 517 ± 12.4 533 ± 19.6 500 ± 64.1 506 ± 13.8 n.s.
CO (ml/min) 27.7 ± 1.0 27.3 ± 1.4 25.2 ± 3.1 28.4 ± 1.5 n.s.

Fetus HR (/min) 183 ± 22.6 181 ± 7.5 209 ± 38.2 176 ± 11.0 n.s.
CO (µl/min) 83.1 ± 7.9 73.9 ± 5.9 81.7 ± 10.7 62.9 ± 7.6 n.s.
SV (µl 0.47 ± 0.031 0.41 ± 0.031 0.41 ± 0.36 0.36 ± 0.035 n.s.

HR: heart rate, CO: cardiac output, SV: stroke volume